Blueprint Medicines BPMC announced positive top-line results from the Part 2 of PIONEER clinical trial of AYVAKIT (avapritinib) in patients with non-advanced systemic mastocytosis (SM). The Part 2 of ...
In this segment, Dr Luskin examines how patient-related factors influence treatment decisions in blastic plasmacytoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback